Press release
Chemotherapy-Induced Nausea and Vomiting Drugs Market Report Forecasts High Growth by 2022 - Scalar Market Research
Download Free Sample: https://www.scalarmarketresearch.com/request-sample.php?id=773
Nausea and Vomiting are the most common side-effects associated with the cancer treatment. Most chemotherapy agents used in cancer treatments causes some degree of nausea and vomiting. The goal of the Chemotherapy-induced Nausea and Vomiting (CINV) Drugs and other Cancer Supportive Care Products is to improve the quality of patient’s life, by preventing or treating the associated conditions and symptoms. The market can be segmented into Serotonin receptor antagonist and NK1 receptor antagonist. Key players in the market are focusing on broadening their product portfolio by means of acquisitions and collaboration.
Enquiry Before Buying: https://www.scalarmarketresearch.com/enquire-before-buy.php?id=773
KEY PREMIUM INDUSTRY INSIGHTS
1. The key reasons driving the growth of the Chemotherapy-induced Nausea and Vomiting Drugs market includes increasing prevalence of cancer diseases and new product development and innovations.
2. Demand from developing nations is one of the key growth opportunity drivers for this market.
3. However, factors like high cost associated with new drug development may hamper the growth of the Chemotherapy-induced Nausea and Vomiting Drugs Market.
KEY MARKET PLAYERS
Key players in the chemotherapy-induced nausea and vomiting drugs market include:
1.Merck & Co., Inc.
2.GlaxoSmithKline plc
3.Tesaro, Inc.
4.Helsinn Group
5.F. Hoffmann-La Roche Ltd.
6.Heron Therapeutics, Inc.
7.Dr. Reddy's Laboratories Ltd.
8.Acacia Pharma
9.Sun Pharmaceutical Industry Ltd.
10.Otsuka Holdings Co., Ltd.
Browse Report: https://www.scalarmarketresearch.com/market-reports/chemotherapy-induced-nausea-and-vomiting-drugs-market
About Scalar Market Research
Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.
Find out more about our services at: www.scalarmarketresearch.com
Contact:
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: sales@scalarmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy-Induced Nausea and Vomiting Drugs Market Report Forecasts High Growth by 2022 - Scalar Market Research here
News-ID: 593080 • Views: …
More Releases from Scalar Market Research
Cloud Field Service Management Market
Cloud Field Service Management is a system developed for managing field operations through a mobile application or software. This software solution enables the companies to manage field resources such as vehicle location, field worker activity and ensure delivery of spare parts to the operational field. This solution assigns work according to the skills and geographical location of the field employee and checks inventory for the availability of spare parts. The…
Oncology Information System Market Report Forecasts Impressive Growth by 2022 - …
Healthcare sector is extensively using digital tools to store patient data. Oncology information system tracks patient information such as diagnostic details and patient history. This also includes additional information such as treatment patterns and prescriptions. Overall, the key services provided by the system are patient information systems, treatment planning systems, consulting services, and implementation and maintenance systems. This report studies the current and future aspects of the oncology information system…
DC Torque Tool Market Segmentation and Competitor Analysis Report - Scalar Marke …
DC torque tool could be a tool designed to use torque alternative device or to live torque. Historically manual torque tools were for the most part current in mechanical activities; but, within the past few years, adoption of DC torque tools has augmented considerably. DC torque tools will apply torque a lot of quicker than manual torque applying strategies and might additionally produce a high torque force as compared to…
Public Safety LTE Market scrutinized in top research report for the forecast 201 …
The government initiatives toward public safety, ability issues, and rising demand for remote-controlled operations and remote police work are propellant the expansion of the marketplace for infrastructure and services. The high range of users during this phase is that the major reason for a high share of this application within the aforementioned market. The Govt. initiatives on national safety and increasing expenditures on public safety and security square measure expected…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
